Q1 2020 Biopharma Report
Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q1 2020 Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life sciences deal landscape.
In this report you can find an overview and analysis of the following across the biopharma market in the US, Europe, and Asia (Japan and China):
- Key performance indicators for the life science market
- IPO and private financing activity and performance
- Deal activity for strategic partnership and M&A
- A look ahead and our predictions of the future